2nd Edition of EuroSciCon Conference on

Stem Cell

Theme: Advancing new progression & horizon of Stem Cell research

Event Date & Time

Event Location

Stockholm, Sweden

16 years of lifescience communication

Previous Conference Performers / Professionals From Around The Globe

Conference Speaker


Mossakowski Medical Research Centre

Conference Speaker


Wroclaw Medical University

Conference Speaker


Agricultural University

Conference Speaker

Marina Wiklander


Conference Speaker


Agricultural University Georgia

Conference Speaker


Pulp and Paper Institute of biotechnology

Conference Speaker


Agricultural University

Conference Speaker


Agricultural University Georgia

Conference Speaker


Qatar University

Conference Speaker


University of Strasbourg France

Conference Speaker


University of the Punjab

Conference Speaker


Central Oilworkers Hospital

Tracks & Key Topics

Stem Cell 2019


Theme: Advancing new progression & horizon of Stem Cell research

After successful completion of Stem cells 2018, The 2nd Edition of EuroSciCon Conference Stem Cell 2019 is held by EuroSciCon and the conference is scheduled for May 9-10, 2019 in Stockholm, Sweden.  It focuses on the major issues of Stem Cell Biology field includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.

Aim and Objectives:

Stem Cell 2019 Congress aim is to provide the exclusive research topics where all the participants can be up to date with the Latest developments in the Stem Cell Research. Meeting on Stem Cell 2019 extreme Objective is to be the Premier and Exclusive medicinal services gathering in the overall areas. The estimations of Cell and Stem Cell 2019 are Innovation, Quality, Integrity, Knowledge and Patient care.

What’s New?

Stem Cell 2019 includes international attendee workshops, lectures, and symposia, including a designated registration area, a refreshment break, and gala lunch. So come and join the leading expertise people in the field of Cell and Gene therapy and allied professionals from May 9-10, 2019 in Stockholm, Sweden to keep up with the rapidly accelerating pace of change that is already having an impact on the field of Cell and Gene Therapy and will continue to in the future.

Why attend???

With individuals from all around the globe concentrated on finding out about Stem Cell and Regenerative Medicine and its advances; this is your best chance to achieve the biggest collection of members from the Stem Cell and Regenerative Medicine people group. Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations Heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cells research, regenerative medicine can be as Target Audience.

Who Are Attending?


Opportunities for Conference Attendees

For Researchers &Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group Registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event 
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering   
  • Marketing and Networking with clients

Euroscicon organizes Stem Cells Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands Russia, Bulgaria, France, with solitary subject of quickening logical revelations. 





Past Conference Report (Stem Cell 2018)

The EuroSciCon Conference on Stem Cell (Stem Cell 2018) hosted by EuroSciCon Ltd took place at  Hyatt Place, Amsterdam Airport, Amsterdam, Netherlands during April 16- 17, 2018. It was organized by EuroSciCon Ltd and generous response was received from the Editorial Board Members of  EuroSciCon Ltd Journals as well as from eminent scientists, talented researchers, and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from EuroSciCon Ltd. The two-day program witnessed thought provoking keynote and plenary presentations from experts in the field of Stem Cell research field highlighting the theme, "Frontiers in Stem Cells & turning ideas into reality ".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Stem Cell Apoptosis And Signal Transduction
  • Cancer Stem Cells
  • Stem Cell Transplantation & Techniques
  • Reprogramming Stem Cells: Computational Biology
  • Stem Cell Banking
  • Stem Cell Biomarkers
  • Epigenetics
  • Plant Stem Cells
  • Veterinary Stem Cell
  • Nanotechnology In Stem Cells
  • Tissue Regeneration & Therapeutics
  • Alternative Medicine In Stem Cell
  • Novel Stem Cell Technologies
  • Stem Cell Product Development & Commercialization
  • Ethical Issues In Stem Cell Research

The highlights of the meeting were form the eminent keynote lectures from

  • Mark Engelman, UK
  • Robert Bowen, USA
  • Olexandr Korchynskyi, Poland
  • Chandan R Bora, Trinidad and Tobago
  • Zeliha Selamoglu, Turkey

Stem Cell 2018 played an important role in promoting multidisciplinary interactions between science and medicine to enhance research in Stem Cells and Biotechnology. The program covered current and emerging research innovations in the field of Stem Cells and Biotechnology.

We would specially thank the Moderator of the Utku AVCITurkey for his contribution to the conference.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Stem Cell 2018 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, EuroSciCon Ltd would like to announce the commencement of " 2nd Edition of EuroSciCon Conference on Stem Cell " during May 9-10, 2019 at Stockholm, Sweden.

Let us meet again @ Stem Cell 2019




Globally Regenerative Medicines market size is predicted to reach USD 30,237 million by 2022. Recently, Regenerative Medicine has emerged with full of promise approaches to treat and cure complex degenerative disorder and to support, restore the function of tissues and cells in other therapies. North America leads the way of a global market in 2015 and it is expected to remain ascendant during 2015-2022. Stem Cells are used to treat cancer and different immune system diseases. And now Stem Cells are suspected for the treatment in Neurodegenerative Diseases, wound healing, spinal cord injury, etc. The worldwide Stem cell & regenerative medicines market is divided according to product type, application, sources, geography and end users. By the product type stem cells market is again divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines have the capability to regenerate, repair & replace tissues of the organ which are affected due to injury, natural aging process, and some diseases. These medicines are able to restore the performance of cells & tissues, therefore, now researchers are focusing on the new technologies which are basically based on biologics, genes, somatic and stem cells as well. The proliferation and differentiation is the major capability of stem cells owing to which they are of importance in this field. Utilization of Nano-materials in immunomodulation, drug delivery, and wound care make the growth the avenues for the regenerative medicines market.             

The regenerative medicine market is broadly divided into three categories namely biologically derived materials, synthetic materials, and genetically engineered materials. The Synthetic materials and biologically derived materials have high demands in the market due to its higher efficiency as compared to other naturally derived materials.

Raw Material Analysis:

For biologically derived materials for regenerative medicines, demand is higher compared to other naturally derived materials due to its efficiency. The procedures say synthetic materials have used hydrogel in tissue engineered scaffolds. This report provides a complete overview of the growth rate of regenerative medicines and stem cells. It is believed that the stem cell market will grow appreciably. Regenerative medicine is a wider field which encompasses the potential to acquire its achievement. Financially, investment in this field is all by grants, private inventors, and publicly traded stocks. Looking ahead, the regenerative medicine and stem cells market is promising for a number of powerful reasons including. 

Stem Cell-A new opportunity in Cosmeceuticals Market:

The market was evaluated at $42.24 billion in 2016 and is expected to reach a value of $68.72 billion by 2022, witnessing a CAGR of 8.52% during the predicted period, 2017-2022.

Cosmeceuticals are the emerging market and so there are lots of opportunities lies in the market that is needed to be explored. North America has been declared as the second largest in the market of cosmeceuticals that has estimated for a share of 31% approx. in 2016.

The United States is the major industry for the organic and in North America natural cosmetic products which shares 85% approx. in 2016 with a market value of $10.62 billion. Whereas, the Asia Pacific is the third largest industry for skin care products market which estimated a share of 22% approx. in 2016.

Global Market Study of Stem Cells & Regenerative Medicine:

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

Europe: The regenerative medicine & stem cells market is expected to reach USD 13.578 billion by 2022 from USD 5.06 billion in 2016 at a CAGR of 21.80% during the period 2016-2022.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.



Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!